Published in Ned Tijdschr Geneeskd on January 21, 2006
[Three patients with autoimmune hepatitis: the importance of early diagnosis and remission]. Ned Tijdschr Geneeskd (2005) 1.37
Value of molecular analysis of Wilson's disease in the absence of tissue copper deposits: a novel ATP7B mutation in an adult patient. Neth J Med (2008) 1.77
Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology (2012) 1.73
NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci (2008) 1.70
Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet (2010) 1.55
Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med (2005) 1.48
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther (2011) 1.42
Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther (2012) 1.27
Somatostatin analogues reduce liver volume in polycystic liver disease. Gut (2008) 1.25
The long-term outcome of patients with polycystic liver disease treated with lanreotide. Aliment Pharmacol Ther (2011) 1.17
Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus. Neth J Med (2009) 1.15
Pharmacological management of pain in chronic pancreatitis. Dig Liver Dis (2006) 1.13
Mevalonate kinase deficiency: Evidence for a phenotypic continuum. Neurology (2004) 1.08
Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic review. Neth J Med (2011) 1.04
On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis (2011) 1.04
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis (2006) 1.01
Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment Pharmacol Ther (2007) 1.00
[Serious complications following (removal after) ingestion of a partial denture]. Ned Tijdschr Tandheelkd (2008) 1.00
Hereditary periodic fever and reactive amyloidosis. Clin Exp Med (2005) 0.99
Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review. Neth J Med (2007) 0.98
A case of esophageal duplication cyst with a 13-year follow-up period. Endoscopy (2005) 0.96
Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford) (2005) 0.94
Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. Aliment Pharmacol Ther (2011) 0.90
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature. Neth J Med (2013) 0.88
CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis. Dig Liver Dis (2006) 0.87
Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet (2005) 0.86
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent. Aliment Pharmacol Ther (2006) 0.86
Prevalence of hepatitis C in the general population in the Netherlands. Neth J Med (2008) 0.85
Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency. Clin Exp Immunol (2009) 0.84
FDG-PET scanning in the diagnosis of gastrointestinal cancers. Scand J Gastroenterol Suppl (2004) 0.83
Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. J Intern Med (2004) 0.82
Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum. Neth J Med (2011) 0.81
Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid (2005) 0.81
Systematic review: the management of hepatic cyst infection. Aliment Pharmacol Ther (2014) 0.80
Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis. Rheumatology (Oxford) (2008) 0.80
[Serious complications following removal of an ingested partial denture]. Ned Tijdschr Geneeskd (2007) 0.80
[A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)]. Ned Tijdschr Geneeskd (2007) 0.80
Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathways. Neth J Med (2010) 0.80
Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients. J Viral Hepat (2010) 0.79
Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect (2005) 0.79
Lovastatin inhibits formation of AA amyloid. J Leukoc Biol (2008) 0.78
Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era. Neth J Med (2014) 0.78
Treatment of hepatitis C monoinfection in adults--Dutch national guidelines. Neth J Med (2013) 0.77
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection. Neth J Med (2012) 0.77
Genetic basis of chronic pancreatitis. Scand J Gastroenterol Suppl (2002) 0.77
Clinical features of liver involvement in adult patients with listeriosis. Review of the literature. Infection (2007) 0.77
AL amyloidosis enhances development of amyloid A amyloidosis. Br J Dermatol (2007) 0.77
Comment on: How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? Dig Liver Dis (2009) 0.76
Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia. Br J Dermatol (2005) 0.76
Hyperimmunoglobulinaemia D syndrome in India: report of two siblings with a novel mutation. Ann Rheum Dis (2006) 0.76
Hepatitis C virus infection management in 2012. Panminerva Med (2012) 0.76
Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis. Neth J Med (2011) 0.76
[Liver abscesses as a complication of Crohn's disease]. Ned Tijdschr Geneeskd (2005) 0.75
Absence of an association of the IBD2 locus gene keratin 8 and inflammatory bowel disease in a large genetic association study. Dig Liver Dis (2004) 0.75
Rationale and design of the virological response and ribavirin dosage (VIRID) study in hepatitis. Neth J Med (2008) 0.75
Current clinical care compared with new Dutch guidelines for hepatitis C treatment. Neth J Med (2009) 0.75
The Netherlands Journal of Medicine's hit list: best cited articles in 2003. Neth J Med (2005) 0.75
[Dutch study on the optimal treatment strategy for patients with a first or second occurrence of gastro-oesophageal variceal bleeding: the TIPS-TRUE trial]. Ned Tijdschr Geneeskd (2008) 0.75
[Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias]. Ned Tijdschr Geneeskd (2006) 0.75
UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls. Pharmacogenomics J (2007) 0.75
[From gene to disease; hepatocystin and autosomal dominant polycystic liver disease]. Ned Tijdschr Geneeskd (2003) 0.75
Hepatosplenic schistosomiasis: a review. East Afr Med J (2004) 0.75
[New drugs available more quickly for the right patient]. Ned Tijdschr Geneeskd (2016) 0.75
How the concept of biochemical response influenced the management of primary biliary cholangitis over time. Neth J Med (2016) 0.75